Literature DB >> 14976653

The impact of race on survival in nasopharyngeal carcinoma: a matched analysis.

Neil Bhattacharyya1.   

Abstract

OBJECTIVE: To determine if nasopharyngeal carcinoma (NPC) exhibits significant prognostic differences in Chinese versus white patients.
METHODS: From the Surveillance, Epidemiology, and End Results database for the time period 1988 to 2000, all cases of NPC were extracted and staging variables computed. To each case of NPC diagnosed in a Chinese patient, a case of NPC in a white patient was randomly matched for age at diagnosis, gender, grade, stage, and treatment modality. Kaplan-Meier survival analysis was then conducted for the matched groups comparing overall survival and disease-specific survival both for the overall matched cohort and stage stratified cohorts.
RESULTS: Among 1,520 cases of NPC, 338 were identified in Chinese patients with staging information. Of these, 171 were successfully matched to white patients. Average age at presentation was 51.5 years with a 3:1 male predominance. Overall survival was substantially better for Chinese patients (mean survival, 94 months; median survival, 95 months) than for white patients (81 months and 64 months, P =.037). Stratified for stage, overall survival was better for Chinese patients for stage 3 but not stage 4 disease (P =.012 and P =.447, respectively). Disease-specific survival was not substantially different between Chinese patients (mean survival, 116 months) and white patients (mean survival 117 months, P =.99). No differences in disease-specific survival were identified for race when stratified by stage (all P >.05).
CONCLUSIONS: Although overall survival is better for Chinese patients with NPC compared with white patients, disease-specific survival is similar between these racial groups. These data suggest that the biological behavior of NPC is relatively independent of race.

Entities:  

Mesh:

Year:  2004        PMID: 14976653     DOI: 10.1016/j.amjoto.2003.11.005

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  12 in total

1.  Simultaneous integrated boost intensity-modulated radiotherapy (SIB‑IMRT) in nasopharyngeal cancer.

Authors:  Evangelia Peponi; Christoph Glanzmann; Guntram Kunz; Christoph Renner; Katja Tomuschat; Gabriela Studer
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

2.  A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma.

Authors:  Myriam Loyo; Mariana Brait; Myoung S Kim; Kimberly L Ostrow; Chunfa C Jie; Alice Y Chuang; Joseph A Califano; Nanette J Liégeois; Shahnaz Begum; William H Westra; Mohammad O Hoque; Qian Tao; David Sidransky
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

3.  Impact of Race, Ethnicity, and Socioeconomic Status on Nasopharyngeal Carcinoma Disease-Specific and Conditional Survival.

Authors:  Ashley O London; Liam W Gallagher; Rahul K Sharma; Daniel Spielman; Justin S Golub; Jonathan B Overdevest; Carol H Yan; Adam DeConde; David A Gudis
Journal:  J Neurol Surg B Skull Base       Date:  2021-12-29

4.  Racial differences in nasopharyngeal carcinoma in the United States.

Authors:  Yu Wang; Yawei Zhang; Shuangge Ma
Journal:  Cancer Epidemiol       Date:  2013-09-12       Impact factor: 2.984

5.  Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.

Authors:  Ilona Argirion; Katie R Zarins; Julie J Ruterbusch; Patravoot Vatanasapt; Hutcha Sriplung; Erlene K Seymour; Laura S Rozek
Journal:  Cancer       Date:  2019-09-16       Impact factor: 6.860

6.  Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.

Authors:  Xinsa Fu; Congxiang Shen; Huigang Wang; Fang Chen; Guanxue Li; Zhong Wen
Journal:  BMC Cancer       Date:  2017-07-11       Impact factor: 4.430

7.  Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.

Authors:  Jian Sun; Zhongying Huang; Zheyu Hu; Rui Sun
Journal:  J Transl Med       Date:  2017-05-30       Impact factor: 5.531

8.  Inhibiting eEF-2 kinase-mediated autophagy enhanced the cytocidal effect of AKT inhibitor on human nasopharyngeal carcinoma.

Authors:  Yuan-Yuan Zhao; Ying Tian; Lin Liu; Jian-Hua Zhan; Xue Hou; Xi Chen; Ting Zhou; Yan Huang; Li Zhang
Journal:  Drug Des Devel Ther       Date:  2018-08-29       Impact factor: 4.162

9.  Association of Race/Ethnicity, Stage, and Survival in Oral Cavity Squamous Cell Carcinoma: A SEER Study.

Authors:  Alison J Yu; Janet S Choi; Mark S Swanson; Niels C Kokot; Tamara N Brown; Guofen Yan; Uttam K Sinha
Journal:  OTO Open       Date:  2019-12-10

10.  Polyphyllin G induce apoptosis and autophagy in human nasopharyngeal cancer cells by modulation of AKT and mitogen-activated protein kinase pathways in vitro and in vivo.

Authors:  Jui-Chieh Chen; Ming-Ju Hsieh; Chih-Jung Chen; Jen-Tsun Lin; Yu-Sheng Lo; Yi-Ching Chuang; Su-Yu Chien; Mu-Kuan Chen
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.